Redivus Health Recognized as Finalist in Fierce Innovation Awards: Healthcare
OLATHE, Kan. — Redivus Health announced that the company has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition 2017, an awards program from the publisher of FierceHealthcare. Redivus Health was recognized as one of three finalists in the Clinical Information Management category. Redivus Health was selected as a finalist for its innovative, industry-leading product, which improves patient care by providing physicians, nurses and paramedics with actionable, clinical guidance during a critical care event. The Redivus mobile application, combined with a cloud-based platform, delivers evidence-based protocols to enhance diagnostic and treatment accuracy for cardiac arrest, stroke and sepsis. Hospitals and EMS providers using Redivus can expect to reduce risk, improve quality, reduce costs, and increase compliance. All applications were evaluated based on the following criteria: Competitive Advantage, Financial Impact/Value, Market Need, and Overall Innovation. Applicants with the top three scores in each category were selected as finalists. “Everyone deserves safe and effective medical care,” says Jeff Dunn, founder and CEO. “Redivus Health is putting innovation to work to reduce medical error and save lives. We’re thrilled to be recognized along with other companies working to improve today’s healthcare systems.” Finalists were selected by a distinguished panel of judges from renowne...
CONCLUSION: Our meta-analysis of 20,605 patients who participated in large RCTs demonstrate improved MBG scores and ST segment resolution>50% with aspiration thrombectomy compared to PCI alone, but no differences in mortality, reinfarction, TVR and stroke rates at 30 days. Our study supports the latest ACC/AHA/SCAI focused update document that recommends against the routine use of aspiration thrombectomy during primary PCI. PMID: 29241844 [PubMed - as supplied by publisher]
Dr. Tara Narula joins "CBS This Morning: Saturday" to discuss a new study that shows why those without traditional heart disease risk factors may still be susceptible to heart attacks and stroke and how mandatory screening for critical congenital heart disease in infants affected death rates.
CONCLUSIONS: Herpes zoster was associated with an increased risk of dementia, independent of potential confounding factors. Antiviral treatment might be protective in preventing dementia in patients with herpes zoster. PMID: 29244265 [PubMed - as supplied by publisher]
Conclusion: In summary, our findings indicate that severe CAS could play a role in cognitive decline. Further studies should be conducted using larger patient cohorts without ischemic brain lesions and with balanced vascular risk profiles to investigate impact of CAS on cognition. There was no association between severe CAS and depressive symptoms in the present study. As patients with severe CAS did not exhibit physical symptoms, HRQoL was better for those patients than for patients with lower extremity PAD. PMID: 29238393 [PubMed]
Authors: Ohshima T, Dash C, Belayev A, Yamamoto T, Goto S, Kato Y Abstract The use of 8-F balloon guide catheter (BGC) for proximal flow control was previously shown to prevent distal embolic complications during mechanical clot retrieval in patients with acute ischemic stroke. In this retrospective study, the utility of 8-F BGCs for proximal flow control during endovascular coiling of anterior circulation aneurysms was investigated. Patients who underwent endovascular coiling for anterior circulation aneurysms between August 2013 and December 2016 were retrospectively analyzed. Among a total of 152 patients includ...
We present a case of a patient who presented with recurrent posterior circulation infarcts despite optimized medical management. On imaging, he was found to have external anatomical vertebral artery muscular and/or osseous compression leading to repetitive vascular injury and strokes. Recurrent intimal injury and vertebral artery to intracranial emboli despite anticoagulation and subsequent dual antiplatelet therapy necessitated definitive operative management. Surgical bypass, external surgical decompression, reconstructive endovascular, and deconstructive endovascular techniques were carefully considered. A deconstructiv...
Conclusions OTP is a prehospital and in-hospital workflow-based indicator. In this single-center study, OTP was found to independently affect functional outcomes after endovascular stroke treatment. PMID: 29237321 [PubMed - as supplied by publisher]
To show that progress has been made in stroke intervention, it is possible to cite several substantial advances over the past year. Beginning with a clinical highlight: three randomised trials1 –3 that tested the safety and efficacy of patent foramen ovale (PFO) closure after a cryptogenic stroke reported their results simultaneously. The CLOSE trial1 enrolled patients who had a recent PFO-attributed stroke associated with either an atrial septal aneurysm or a large, right-to-left intera trial shunt.
The effectiveness of endovascular treatment in patients with anterior circulation ischaemic stroke due to large artery occlusion is firmly established, although optimal anaesthesia for the procedure remains contentious. Studies have suggested that endovascular treatment under general anaesthesia (GA) is associated with a worse outcome than when treatment is done without GA. However, because patients with more severe stroke and comorbidities are more likely to receive GA, there is potential for confounding by indication.
Worse outcomes after endovascular thrombectomy were associated with GA, after adjustment for baseline prognostic variables. These data support avoidance of GA whenever possible. The procedure did, however, remain effective versus standard care in patients treated under GA, indicating that treatment should not be withheld in those who require anaesthesia for medical reasons.